Frontlight ResearchEarly access
Trial site
Reggio Calabria
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia3 trials
- Myelodysplastic syndromes2 trials
- Myeloproliferative neoplasms2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Multiple sclerosis1 trial
- Thalassaemia1 trial
- Phase
- Phase 22 trials
- Phase 31 trial
- Phase 41 trial
- Status
- Active, not recruiting3 trials
- Terminated2 trials
- Completed1 trial
- Lead sponsor
- Novartis Pharmaceuticals6 trials
Running trials
Active, not recruiting
ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients
Active, not recruiting
Active, not recruiting
Closed trials
Terminated
Terminated
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 12 Nov 2026